10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) said management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:50 a.m. ET. A live webcast will be available via the company's Investors website and archived for at least 30 days.

News Market Reaction – TXG

-1.62%

4 alerts

-1.62% News Effect

-$39M Valuation Impact

$2.39B Market Cap

0.1x Rel. Volume

On the day this news was published, TXG declined 1.62%, reflecting a mild negative market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $39M from the company's valuation, bringing the market cap to $2.39B at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 3 Start time: 11:50 a.m. Eastern Time Webcast replay window: 30 days

3 metrics

Conference date March 3 TD Cowen 46th Annual Health Care Conference fireside chat

Start time 11:50 a.m. Eastern Time Scheduled time for the TD Cowen conference fireside chat

Webcast replay window 30 days Webcast available on company’s investor website after event

Market Reality Check

Price: $20.81 Vol: Volume 749,860 is below t...

low vol

$20.81 Last Close

Volume Volume 749,860 is below the 20-day average of 2,768,913, indicating muted trading ahead of this conference update. low

Technical Shares at $19.57 are above the 200-day MA of $14.19 and 16.94% below the 52-week high.

Peers on Argus

TXG was down 3.19% with light volume while key peers like CERT, OMCL, PHR, SDGR,...

1 Down

TXG was down 3.19% with light volume while key peers like CERT, OMCL, PHR, SDGR, and GDRX all showed modest gains. Momentum scanner only flagged WEAV to the downside, reinforcing that TXG’s weakness appeared stock-specific rather than sector-driven.

Historical Context

5 past events · Latest: Feb 12 (Negative)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 12	Earnings results	Negative	-8.6%	Q4 and full-year 2025 results with modest growth and narrowed losses.
Feb 04	AI partnership	Positive	-1.1%	Partnership with PharosAI to build a large multimodal cancer dataset.
Jan 22	Earnings date set	Neutral	-3.5%	Announcement of date and webcast details for Q4 and FY 2025 results.
Jan 15	Reverse stock split	Neutral	+1.3%	Amcor completed a 1-for-5 reverse stock split, a peer-sector event.
Jan 12	Clinical study launch	Positive	-3.2%	Launch of 1,000-patient autoimmune disease study with Brigham & Women’s.

Pattern Detected

Recent history shows TXG often trading lower following earnings, partnerships, and research collaborations, suggesting a pattern of negative or cautious price reactions even to ostensibly constructive news.

Recent Company History

Over the last few months, TXG has reported Q4 and full-year 2025 results, issued an outlook for 2026, and detailed these metrics further in a 10-K and 8-K. It also announced an AI-focused cancer research partnership and a large autoimmune disease study targeting 1,000 patients. Despite these strategic initiatives, shares declined after several of these updates, framing today’s routine conference participation within a backdrop of cautious market responses.

Market Pulse Summary

This announcement highlights TXG’s upcoming fireside chat at a major healthcare conference on March ...

Analysis

This announcement highlights TXG’s upcoming fireside chat at a major healthcare conference on March 3, with a webcast available to investors for at least 30 days. Framed against recent earnings, strategic partnerships, and a large autoimmune study launch, the event offers management another platform to discuss its outlook. Investors tracking the story may focus on any incremental color around growth, profitability trends, and execution of recent collaborations and clinical research initiatives.

AI-generated analysis. Not financial advice.

PLEASANTON, Calif., Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, at 11:50 a.m. Eastern Time.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube. 

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-participate-in-the-46th-annual-td-cowen-health-care-conference-302692977.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics (TXG) present at the TD Cowen Health Care Conference?

10x Genomics will present on March 3, 2026 at 11:50 a.m. Eastern Time. According to the company, members of management will appear in a fireside chat at the TD Cowen 46th Annual Health Care Conference on that date and time.

How can investors watch the 10x Genomics (TXG) fireside chat on March 3, 2026?

Investors can watch via a live webcast on the company's Investors website. According to the company, the webcast will be hosted on its investor site and archived for replay for at least 30 days after the event.

Will the 10x Genomics (TXG) webcast from the TD Cowen conference be available after the event?

Yes, the webcast will be archived and replayable for at least 30 days after the event. According to the company, interested parties can access the archived fireside chat on the Investors section of its website for that period.

What time is the 10x Genomics (TXG) fireside chat scheduled in ET and how long is availability?

The fireside chat is scheduled for 11:50 a.m. Eastern Time on March 3, 2026, and the webcast replay will be available for at least 30 days. According to the company, the live session precedes the archived replay window.

Where on the 10x Genomics (TXG) website will the TD Cowen webcast be hosted?

The webcast will be hosted in the Investors section of the company's website. According to the company, viewers should go to the Investors page at the provided URL to access both the live stream and the archived replay.

Who from 10x Genomics (TXG) will participate in the TD Cowen fireside chat?

Members of 10x Genomics' management team will participate in the fireside chat. According to the company, multiple members of its management team are scheduled to appear, though specific individual names were not listed in the announcement.